With growing health needs, is digital the best medicine?
The current health care environment requires evaluation of both what you do and how you do it. Let EY help you optimize, grow, and protect your business.
Over the decade, there has been robust growth in precision therapeutics as biopharmas seek to develop medicines to be targeted for specific patient populations.
As demographic, digital and financial forces transform how health care is delivered, it’s not first-in-class medicine or technology that determines value it.
Our 14th Global Capital Confidence Barometer finds health executives have high expectations for M&A in 2016, with activity anticipated to remain above historical sector averages.
In this edition, we focus on the drivers of reshaping how the world approaches health care, including spending, technology and mindset.
How distributed ledgers can improve provider data management and support interoperability.
The time for inaction is past. Providers should be taking steps now, to prepare—regardless of the MACRA implementation date.
It is an exciting, yet profoundly disruptive time in the health industry as powerful forces intersect to drive industry transformation.
Threats of cyberattacks are real and substantial for health and life sciences. We discuss a protection approach based on pragmatism, global perspectives and relentless vigilance.
Health care organizations are exposed to increased risk in a rapidly changing regulatory and competitive environment. Robust, integrated compliance capabilities are essential for growth.